Artwork

Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

COVID-19 vaccines: your questions answered

34:27
 
Jaa
 

Manage episode 323237398 series 3329558
Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
We asked PJ readers to submit their questions regarding the different COVID-19 vaccines being developed around the world, the phase III trial results and the practicalities of how these vaccines will be administered. In this podcast, Dawn Connelly, features editor and Julia Robinson, clinical and science editor, will try to answer these questions using the latest available information and the help of some external experts. Thanks to Charles Bangham, chair in immunology and co-director of the Institute of Infection at Imperial College London and Stephen Evans, professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine. A link to the infographic referred to in the podcast is here: https://www.pharmaceutical-journal.com/news-and-analysis/infographics/the-race-to-stop-covid-19/20207792.article Please do let us know if you have any outstanding questions regarding the COVID vaccines after listening to this podcast. Email us at dawn.connelly@rpharms.com — if there are enough, we may do another podcast! This podcast is presented by Nigel Praities, Dawn Connelly and Julia Robinson. It was produced by Geoff Marsh.
  continue reading

48 jaksoa

Artwork
iconJaa
 
Manage episode 323237398 series 3329558
Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
We asked PJ readers to submit their questions regarding the different COVID-19 vaccines being developed around the world, the phase III trial results and the practicalities of how these vaccines will be administered. In this podcast, Dawn Connelly, features editor and Julia Robinson, clinical and science editor, will try to answer these questions using the latest available information and the help of some external experts. Thanks to Charles Bangham, chair in immunology and co-director of the Institute of Infection at Imperial College London and Stephen Evans, professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine. A link to the infographic referred to in the podcast is here: https://www.pharmaceutical-journal.com/news-and-analysis/infographics/the-race-to-stop-covid-19/20207792.article Please do let us know if you have any outstanding questions regarding the COVID vaccines after listening to this podcast. Email us at dawn.connelly@rpharms.com — if there are enough, we may do another podcast! This podcast is presented by Nigel Praities, Dawn Connelly and Julia Robinson. It was produced by Geoff Marsh.
  continue reading

48 jaksoa

Todos os episódios

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas